Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Shares Outstanding (Diluted Average): 2010-2024

Historic Shares Outstanding (Diluted Average) for OptimizeRx (OPRX) over the last 13 years, with FY2024 value amounting to $18.3 million.

  • OptimizeRx's Shares Outstanding (Diluted Average) rose 620.15% to $19.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.5 million, marking a year-over-year increase of 620.15%. This contributed to the annual value of $18.3 million for FY2024, which is 682.13% up from last year.
  • Per OptimizeRx's latest filing, its Shares Outstanding (Diluted Average) stood at $18.3 million for FY2024, which was up 682.13% from $17.1 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Shares Outstanding (Diluted Average) ranged from a high of $18.3 million in FY2024 and a low of $14.8 million during FY2020
  • In the last 5 years, OptimizeRx's Shares Outstanding (Diluted Average) had a median value of $17.7 million in 2021 and averaged $17.1 million.
  • In the last 5 years, OptimizeRx's Shares Outstanding (Diluted Average) surged by 1930.52% in 2021 and then crashed by 370.67% in 2023.
  • Over the past 5 years, OptimizeRx's Shares Outstanding (Diluted Average) (Annual) stood at $14.8 million in 2020, then grew by 19.31% to $17.7 million in 2021, then rose by 0.53% to $17.8 million in 2022, then dropped by 3.71% to $17.1 million in 2023, then rose by 6.82% to $18.3 million in 2024.
  • Its Shares Outstanding (Diluted Average) stands at $18.3 million for FY2024, versus $17.1 million for FY2023 and $17.8 million for FY2022.